block
elisa
distinguish
infecti
bovin
rhinotrach
viru
ibrv
infect
anim
vaccin
genedelet
marker
vaccin
saul
kit
haruki
otsuka
malon
kitb
sensit
specif
block
enzymelink
immunosorb
assay
elisa
develop
distinguish
infecti
bovin
rhinotrach
viru
ibrv
infect
anim
immun
glycoprotein
iii
delet
mutant
ibrv
ng
dltkdlgiii
elisa
undilut
test
sera
use
block
bind
antiibrv
monoclon
antibodi
mabgiii
horseradish
peroxidas
hrpo
conjug
antigen
tmb
substrat
use
color
develop
neg
sn
valu
defin
absorb
nm
test
seraabsorb
nm
neg
control
sera
obtain
immun
sera
gnotobiot
cattl
immun
sever
bovin
virus
bovin
antisera
bovin
vesicular
stomat
viru
porcin
antisera
pseudorabi
viru
parvoviru
normal
sera
heterolog
speci
neg
sn
valu
also
obtain
sera
rabbit
twice
vaccin
ibrv
ng
dltkdlgiii
howev
sn
valu
becam
posit
sn
io
day
rabbit
challeng
expos
virul
ibrv
cooper
sera
feedlot
cattl
viru
neutral
vn
titer
neg
sn
valu
sera
neg
vn
titer
posit
sn
valu
consist
observ
indic
ibrv
outbreak
occur
one
feedlot
herd
thirti
nine
sera
feedlot
cattl
vn
titer
posit
sn
valu
one
serum
vn
titer
borderlin
sn
valu
immun
commerci
giii
herpesviru
bovin
herpesvirusi
associ
infecti
bovin
rhinotrach
ibr
import
pathogen
cattl
caus
sever
respiratori
infect
conjunct
enceph
loss
milk
yield
metriti
enter
infecti
pustuiar
vulvovaginitisj
balanoposth
ipv
ipb
abort
gibb
reyemamu
ibrv
bhvi
first
isol
howev
increas
popul
stress
livestock
product
sever
respiratori
aspect
ibrv
infect
becam
increasingli
promin
usa
feedlot
along
conjunct
calv
abort
storm
incontact
cow
sever
respiratori
form
ibr
also
becam
widespread
western
european
countri
edward
ackermann
et
al
variou
method
use
diagnos
control
ibr
countri
test
slaughter
polici
follow
other
modifiedl
kill
ibrv
vaccin
use
control
diseas
howev
despit
variou
control
program
ibr
continu
increas
furthermor
within
european
commun
free
traffic
anim
begin
januari
could
acceler
spread
diseas
henc
urgent
need
better
control
erad
program
ackermann
et
al
b
switzerland
nation
herd
consist
cattl
includ
breed
anim
test
slaughter
erad
program
initi
year
ago
seroposit
animai
sluhtr
cost
swiss
franc
akernnn
cost
lllintin
program
estim
dditinl
swiss
franc
per
year
although
appropri
small
countri
like
switzerland
seem
unlik
similar
test
slaughter
program
would
feasibl
costeffect
countri
much
larger
cattl
herd
thu
altern
approach
need
one
approach
consider
vaccin
cattl
genet
engin
delet
marker
vaccin
protect
cattl
test
cattl
differenti
diagnost
test
kit
infect
anim
may
distinguish
vaccin
anin
cull
herd
kit
et
al
genedelet
marker
vaccin
differenti
diagnost
test
approach
alreadi
use
worldwid
pseudorabi
control
erad
program
kit
kit
modifiedl
ibrv
vaccin
attenu
function
inactiv
thymidin
kinas
tk
gene
describ
kit
kit
kit
et
al
kit
et
al
kit
et
al
vivo
studi
shown
tkneg
ibrv
vaccin
protect
cattl
clinic
sign
diseas
suggest
may
administ
safe
pregnant
cow
kit
et
al
miiler
et
al
may
note
extens
field
usag
also
shown
tkneg
pseudorabi
vaccin
efficaci
safe
newborn
piglet
sow
stage
gestat
kit
kit
start
parent
tkdelet
ibrv
second
gener
ibrv
marker
vaccin
delet
mutat
major
ibrv
glycoprotein
gene
giii
develop
kit
et
al
present
studi
describ
giii
block
elisa
test
use
conjunct
genedelet
ibrv
marker
vaccin
elisa
test
detect
ibrv
previous
describ
bolton
et
al
collin
et
al
howev
knowledg
first
descript
differenti
ibrv
elisa
test
use
vaccin
marker
triton
extract
prepar
giiiposit
ibrv
ng
dltk
parent
viru
describ
kit
et
al
dilut
determin
titrat
trial
coat
process
kpl
kirkegaard
perri
laboratori
gaithersburg
md
coat
buffer
contain
phosphatebuff
salin
ml
ahquot
ad
well
flatbottom
microtit
plate
plate
incub
overnight
c
supernat
fluid
remov
ml
kpl
block
solut
contain
bovin
serum
albumin
phosphat
buffer
ad
well
plate
incub
overnight
supernat
dump
well
rins
three
time
ten
buffer
g
trizma
g
nazedta
g
nacl
liter
water
adjust
ph
plate
tap
dri
store
kit
kit
coat
buffer
ad
well
design
blank
well
ibrv
antigen
omit
otherwis
blank
well
process
way
well
gnotobiot
g
antisera
viru
antisera
rais
normal
calv
suppli
nvslusda
follow
vn
titer
bovin
viral
diarrhea
singer
g
vn
fasn
titer
nadl
bovin
herpesl
vn
bovin
ifa
titer
bovin
oronaviru
g
ifa
titer
vesicular
stomat
indiana
vn
vesicular
stomat
new
jersey
vn
bovin
respiratori
syncyti
viru
g
vn
g
ifa
titer
antiswin
prv
antibovin
rotoviru
antiporcin
parvoviru
sera
also
suppli
nvslusda
kit
et
al
normal
lamb
chick
fetal
bovin
sera
purchas
gibcobrl
gaithersburg
md
hors
serum
purchas
inovar
biolog
gaithersburg
md
normal
mous
rabbit
sera
obtain
healthi
mice
rabbit
respect
sera
texa
feedlot
cattl
obtain
dr
stewart
mcconnel
dr
richard
mock
texa
veterinari
medic
diagnost
laboratori
amarillo
tx
addit
sera
collect
time
cattl
arriv
feedlot
sera
collect
feedlot
cattl
immun
commerci
giiiposit
ibrv
vaccin
vn
analys
bovin
sera
carri
texa
veterinari
medic
diagnost
laboratori
antiirbv
block
elisa
analys
sera
carri
baylor
colleg
medicin
houston
texa
antiibrv
rabbit
sera
prepar
follow
three
young
femal
new
zealand
rabbit
weigh
kg
prebl
ear
inocul
intramuscularli
x
pfu
marker
vaccin
ibrv
ng
dltkdlgiii
anim
observ
daili
clinic
symptom
diseas
kelli
day
postvaccin
sera
obtain
rabbit
vaccin
intramuscllarli
x
pfu
ibrv
ng
dltkdlgiii
day
second
vaccinatioi
rabbit
bled
challeng
intramuscularli
x
pfu
virul
ibrv
lo
angel
strain
sera
obtain
day
challeng
anim
remain
healthi
vaccin
challeng
rabbit
sera
heat
nun
c
vn
titer
determin
plaqu
reduct
assay
describ
kit
et
al
procedur
use
analog
employ
previous
sensit
antiprv
glycoprotein
block
elisa
distinguishilg
pseudorabiesinfest
vaccin
pig
kit
et
al
kit
kit
plate
two
well
use
blank
well
lack
antigen
two
well
neg
control
fetal
bovin
sera
lack
ibrv
antibodi
two
well
posit
control
sera
ibrv
antibodi
aliquot
ml
test
sera
neg
posit
control
sera
ad
appropri
well
microtit
test
plate
neg
serum
ad
one
blank
well
posit
serum
blank
well
plate
cover
incub
h
room
temperatur
c
fluid
remov
well
rins
three
time
wash
buffer
mm
trishci
ph
mm
nacl
mm
edta
ibrv
monoclon
antibodi
horseradish
peroxidas
conjug
collin
et
al
ad
well
plate
cover
incub
room
temperatur
min
rins
live
time
wash
buffer
tap
dri
wash
final
ml
premix
tmb
substrat
solut
ii
kpl
ad
well
plate
incub
min
ml
stop
solut
contain
sodium
azid
ad
well
color
analyz
read
absorb
nm
absorb
blank
well
subtract
read
well
antigen
monoclon
antibodyconjug
concentr
adjust
valu
neg
control
fetal
calf
sera
valu
posit
control
bovin
antiibrv
sera
result
test
sera
express
sn
valu
defin
test
sampl
divid
neg
control
n
antiibrv
giii
block
elisa
carri
fetal
bovin
sera
gamma
globulinfre
fetal
bovin
sera
normal
hors
lamb
chick
rabbit
mous
sera
demonstr
ratio
sn
valu
nm
test
sampl
valu
nm
fetal
bovin
sera
n
tabl
similarli
bovin
antisera
rotoviru
vesicular
antibovin
respiratori
syncyti
viru
nvslg
nvslg
porcin
antisera
prv
parvoviru
exhibit
sn
valu
sera
suppli
nvslusda
obtain
gnotobiot
g
calv
immun
sever
differ
virus
sn
valu
antisera
calv
immun
ibrv
sera
rabbit
infect
ibrv
show
sn
valu
basi
empir
result
analys
describ
tent
decis
made
consid
n
valu
neg
sn
valu
posit
ibrv
gll
antibodi
caveat
cours
sera
give
sn
valu
consid
borderlin
k
requir
repetit
assay
assay
ddition
sera
collect
anim
antiibrv
block
elisa
carri
sera
collect
feedlot
cattl
vn
titer
sera
cattl
presum
neg
ibrv
antibodi
fig
sera
sn
valu
consist
presumpt
lack
ibrv
antibodi
howev
sera
vn
titer
sn
valu
indic
cattl
probabl
posit
ibrv
antibodi
antiibrv
block
elisa
carri
sera
feedlot
cattl
show
vn
titer
fig
thirtynin
sera
posit
n
valu
os
one
serum
vn
titer
exhibit
borderlin
sn
valu
observ
test
one
herd
cattl
design
smd
red
particularli
instruct
cattl
herd
truck
feedlot
show
evid
distress
arriv
therefor
cattl
sampl
viru
exposur
sera
collect
select
random
bled
buffi
coat
cultur
seven
buffi
coat
sampl
posit
ibrv
ibrv
isol
verifi
vn
analys
fourteen
sera
test
seroposit
vn
conclus
indic
herd
experienc
ibrv
outbreak
time
arriv
feedlot
twenti
six
sera
analyz
posit
antiibrv
block
elisa
test
sn
ibrv
giiiposit
sera
vn
titer
tabl
vn
titer
precaut
calv
vaccin
ibrv
giiiposit
commerci
vaccin
sera
collect
day
arriv
feedlot
show
sera
test
posit
vn
sera
test
posit
antiibrv
giii
biock
elisa
test
includ
serum
neg
vn
tabl
indic
ibrv
antibodi
induc
even
though
vn
antibodi
detect
serum
overal
antiibrv
giii
block
elisa
analys
carri
sera
cattl
vaccin
commerci
giiiposit
ibrv
vaccin
show
vn
titer
fig
one
serum
vn
titer
borderlin
neg
valu
sera
posit
anamnest
respons
second
vaccin
challeng
virul
cooper
strain
ibrv
tabl
antiibrv
block
elisa
analys
show
neg
sn
valu
prevaccin
sera
sera
collect
two
consecut
vaccin
marker
vaccin
sn
valu
becam
posit
ibrv
antibodi
lo
day
challeng
exposur
ibrv
cooper
antiibrv
block
elisa
simpl
accur
reproduc
rapid
model
highli
sensit
specif
glycoprotein
block
elisa
test
distinguish
prvinfect
pig
pig
vaccin
prv
giiidelet
marker
vaccin
kit
kit
ibrv
glyoprotein
use
antigen
block
elisa
test
major
compon
ibrv
particl
ibrv
like
homolog
prv
hsv
gc
glycoprotein
role
initi
attach
viru
particl
heparinlik
receptor
surfac
permiss
cell
delet
probabl
delay
replic
spread
ibrv
vivo
kit
kit
liang
et
al
howev
like
homolog
prv
hsv
gc
ibrv
essenti
viru
replic
indic
altern
mechan
viru
attach
ibrv
classifi
late
protein
ludwig
letchworth
fact
express
high
level
surfac
viru
particl
surfac
virusinfect
cell
also
fact
major
target
induct
cattl
high
level
viru
neutral
antigen
make
ibrv
advantag
reliabl
marker
differenti
diagnost
test
van
drunen
littelvan
den
hurk
et
al
hutch
et
al
high
level
induct
virusneutr
antibodi
import
giii
differenti
diagnost
test
counterbal
reduct
protect
cattl
might
occur
use
ibrv
giii
delet
mutant
vaccin
may
note
even
absenc
giii
sever
import
immunogen
capabl
induc
protect
avail
exampl
ibrv
glycoprotein
gl
giv
homologu
essenti
hsv
glycoprotein
gb
gd
respect
major
antigen
involv
induct
ibrv
neutral
antigen
earli
infect
ludwig
letchworth
ii
ibrv
giv
appear
antigen
consist
stimul
prolifer
lymphocyt
ibrvimmun
anim
hutch
et
al
iii
activ
natur
killer
cell
activ
ibrvinfect
cell
requir
late
viral
glycoprotein
like
cook
et
al
palmer
et
al
iv
protect
itnmun
respons
obtain
inject
individul
ibrv
glycoprotein
giv
giv
inlinllni
provid
best
individu
protect
babiuk
et
al
van
drunen
littelvan
den
hurk
et
al
v
essenti
glycoprotein
gh
meyer
et
al
ibrv
protein
eg
may
contribut
induct
protect
immun
respons
case
complex
herp
virus
neither
theoret
empir
evid
delet
nonessenti
giii
gc
glycoprotein
impair
protect
respons
kit
kit
antiibrv
block
elisa
util
undilut
test
sera
henc
time
consum
labori
dilut
test
sera
prior
addit
antigenco
well
requir
block
elisa
specif
may
seen
observ
high
titer
gnotobiot
antisera
heterolog
virus
normal
sera
heterolog
speci
antisera
pseudorabi
herpesviru
bovin
herpesvirusgav
neg
n
valu
likewis
sera
anim
twice
vaccin
delet
mutant
ibrv
ng
dltkdlgiii
exhibit
neg
sn
valu
sensit
antiibrv
block
elisa
demonstr
detect
antibodi
sera
vnneg
cattl
herd
experienc
ibrv
outbreak
detect
antibodi
calv
vaccin
giiiposit
commerci
vaccin
one
serum
vaccin
show
fals
neg
vn
titer
sn
anoth
calf
fail
seroconvert
vn
strongli
posit
sn
addit
vnposit
vn
field
sera
test
giii
elisaposit
except
one
serum
vn
show
n
close
borderlin
cutoff
valu
separ
neg
posit
sera
final
observ
giii
antibodi
detect
sera
anim
twice
vaccin
marker
vaccin
ibrv
ng
dltkdlgiii
day
postvaccin
suggest
block
elisa
test
suffici
sensit
detect
field
strain
infect
vaccin
cattl
potenti
reactiv
latenc
spread
herd
develop
genedelet
ibrv
marker
vaccin
differenti
diagnost
test
kit
may
facilit
implement
ibrv
controlerad
program
analog
alreadi
undertaken
aujeszki
diseas
